Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

PDA for Kidneys Study

NCT: NCT06658496 · ACTIVE_NOT_RECRUITING

NCT IDNCT06658496
StatusACTIVE_NOT_RECRUITING
Start Date2024-12-19
Completion2026-12-01
SponsorUniversity of Wisconsin, Madison (OTHER)
First posted
Last updated

Brief Summary

The goal of this observational study is to gather more information on kidney oxygen levels in babies with a patent ductus arteriosus (PDA), and evaluate the relationships between kidney oxygen levels, PDA status and kidney injury. Researchers will do this by looking at ultrasound images of the heart, analyzing substances in the urine, and evaluating oxygen levels in the kidneys.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.

↑